Novavax Inc (NVAX)

Deferred Revenue

$86.58M

Quarterly · Period ending: · USD

NVAX logo

NVAX Deferred Revenue

Latest reported$86.58M
NVAX Quarterly Deferred Revenue ($0.00 → $86.58M)
High-resolution chart · PNG

NVAX deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
86,577,000
88,772,000
140,053,000
104,251,000
113,763,000
108,334,000
675,067,000
613,418,000
666,390,000
240,900,000
241,310,000
192,187,000
300,473,000
415,764,000
370,137,000
404,776,000
701,518,000
1,094,232,000
1,422,944,000
1,262,360,000
1,220,073,000
822,809,000
273,228,000
81,814,000
158,851,000
3,113,000
1,678,000
2,590,000
4,188,000
5,943,000
10,010,000
15,365,000
7,683,000
16,377,000
25,625,000
31,464,000
30,028,000
24,679,000
30,079,000
30,157,000
32,807,000
28,907,000
34,469,000
2,500,000
2,500,000
2,500,000
2,500,000
3,000
25,000
57,000
271,000
190,000
2,500,000
78,000
258,000
1,224,000
409,000
397,000
386,000
375,000
2,864,000
2,500,000
0
7,000
54,000
61,000
432,000
0
273,000
0
3,297,000
5,961,000
3,690,000
2,239,000
2,980,000
0
0
0
0
2,500,000
2,813,000
2,084,000
0
0
0
0
0
0
250,000
250,000
250,000
250,000
250,000
250,000
275,000
350,000
425,000
500,000
1,250,000
2,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.